"Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer" (CONTICARE)
Primary Purpose
Rectal Cancer
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Pelvic floor prehabilitation
Sponsored by
About this trial
This is an interventional treatment trial for Rectal Cancer
Eligibility Criteria
Inclusion Criteria:
- Age between 18 and 80 years old
- Total mesorectal excision with colorectal or coloanal anastomosis protected by an ileostomy or a colostomy for rectal cancer
- Absence of anastomotic leakage or stenosis
- Informed consent to participate in the study
- Social security insurance affiliation
Exclusion Criteria:
- History of anal incontinence and/or fecal urgency and/or chronic diarrhea requiring a specific treatment before rectal cancer management
- Absence of ileostomy or colostomy
- Anastomotic leakage
- Sensorial or cognitive disorders impeding pelvic floor rehabilitation exercise
- Pregnant women
- Minors
- Adults under guardianship
Sites / Locations
- CHU AngersRecruiting
- APHP-Hôpital Beaujon
- Clinic Jules Verne
- CHU de PoitiersRecruiting
- CHD VendéeRecruiting
- CHU de ToursRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Prehabilitation
No intervention
Arm Description
The systematic pelvic floor prehabilitation will start 4 weeks before stoma closure and will include 1 sessions per week before stoma closure and 1 sessions per week during 6 weeks following stoma closure. Complementary sessions are allowed if necessary.
No pelvic floor prehabilitation will be proposed before stoma closure. The pelvic floor prehabilitation will be proposed to patients suffering from LARS
Outcomes
Primary Outcome Measures
Severity of Low Anterior Resection Syndrome Score (LARS score)
questionnaire assessing the five symptoms of the Low Anterior Resection Syndrome : fecal incontinence, gas incontinence, stool frequency, stool clustering and urgency.Total score is reported (minimum score :0 / maximal score : 42)
Secondary Outcome Measures
Severity of fecal incontinence symptoms evaluated by the dedicated and validated score : Jorge and Wexner score
questionnaire to assess the severity of fecal incontinence symptoms, including stool frequency, stool and gas leakage, social impact and the frequency of pads.a total score is reported (minimum score :0 / maximal score : 20)
Impact on quality of life evaluated by the dedicated and validated questionnaire
questionnaire quality of life to assess the global quality of life in patients suffering from colorectal cancer Total score is reported
Morbidity of pelvic floor prehabilitation using biofeedback.
Biofeedback prehabilitation requires a small rectal manometry probe. This outcome will evaluate the morbidity of the rectal introduction of the probe following a colorectal anastomosis.
Medico-economic impact of pelvic floor prehabilitation including the fecal incontinence related costs
The fecal incontinence related costs will be quantified by the data obtained from the social security insurance and the patients' estimation. The differential benefit of the pelvic floor prehabilitation will be correlated to the quality of life estimated by the QALYS using the EQ-5D questionnaire.
Full Information
NCT ID
NCT03876561
First Posted
February 7, 2019
Last Updated
April 2, 2020
Sponsor
Nantes University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03876561
Brief Title
"Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer"
Acronym
CONTICARE
Official Title
"Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer"
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Unknown status
Study Start Date
May 27, 2019 (Actual)
Primary Completion Date
October 2021 (Anticipated)
Study Completion Date
May 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nantes University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
There is currently no specific treatment and only few measures to prevent the low anterior resection syndrome (LARS). The LARS often results in a severe alteration of quality of life. This study is designed to assess pelvic floor prehabilitation using biofeedback in the prevention of LARS following total mesorectal excision for cancer. The pelvic floor rehabilitation with biofeedback has already been tested postoperatively in patients suffering from LARS with heterogeneous results. However, this rehabilitation has never been evaluated in the prevention of LARS.
The prehabilitation is an innovative concept currently evaluated in the prevention of functional complications following orthopedic surgery and also prostate surgery. In high-risk abdominal surgery, cardiopulmonary prehabilitation offers satisfying results in terms of morbidity and mortality rates. This study will be the first to assess pelvic floor prehabilitation in the prevention of LARS.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectal Cancer
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
174 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Prehabilitation
Arm Type
Experimental
Arm Description
The systematic pelvic floor prehabilitation will start 4 weeks before stoma closure and will include 1 sessions per week before stoma closure and 1 sessions per week during 6 weeks following stoma closure. Complementary sessions are allowed if necessary.
Arm Title
No intervention
Arm Type
No Intervention
Arm Description
No pelvic floor prehabilitation will be proposed before stoma closure. The pelvic floor prehabilitation will be proposed to patients suffering from LARS
Intervention Type
Procedure
Intervention Name(s)
Pelvic floor prehabilitation
Other Intervention Name(s)
Preoperative rehabilitation
Intervention Description
The systematic pelvic floor prehabilitation will start 4 weeks before stoma closure and will include 1 session per week before stoma closure and 1 session per week during 6 weeks following stoma closure. The prehabilitation will be performed according to a predefined protocol based on a biofeedback strategy.
Primary Outcome Measure Information:
Title
Severity of Low Anterior Resection Syndrome Score (LARS score)
Description
questionnaire assessing the five symptoms of the Low Anterior Resection Syndrome : fecal incontinence, gas incontinence, stool frequency, stool clustering and urgency.Total score is reported (minimum score :0 / maximal score : 42)
Time Frame
6 months following stoma closure
Secondary Outcome Measure Information:
Title
Severity of fecal incontinence symptoms evaluated by the dedicated and validated score : Jorge and Wexner score
Description
questionnaire to assess the severity of fecal incontinence symptoms, including stool frequency, stool and gas leakage, social impact and the frequency of pads.a total score is reported (minimum score :0 / maximal score : 20)
Time Frame
6 months following stoma closure
Title
Impact on quality of life evaluated by the dedicated and validated questionnaire
Description
questionnaire quality of life to assess the global quality of life in patients suffering from colorectal cancer Total score is reported
Time Frame
6 months following stoma closure
Title
Morbidity of pelvic floor prehabilitation using biofeedback.
Description
Biofeedback prehabilitation requires a small rectal manometry probe. This outcome will evaluate the morbidity of the rectal introduction of the probe following a colorectal anastomosis.
Time Frame
6 months following stoma closure
Title
Medico-economic impact of pelvic floor prehabilitation including the fecal incontinence related costs
Description
The fecal incontinence related costs will be quantified by the data obtained from the social security insurance and the patients' estimation. The differential benefit of the pelvic floor prehabilitation will be correlated to the quality of life estimated by the QALYS using the EQ-5D questionnaire.
Time Frame
6 months following stoma closure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age between 18 and 80 years old
Total mesorectal excision with colorectal or coloanal anastomosis protected by an ileostomy or a colostomy for rectal cancer
Absence of anastomotic leakage or stenosis
Informed consent to participate in the study
Social security insurance affiliation
Exclusion Criteria:
History of anal incontinence and/or fecal urgency and/or chronic diarrhea requiring a specific treatment before rectal cancer management
Absence of ileostomy or colostomy
Anastomotic leakage
Sensorial or cognitive disorders impeding pelvic floor rehabilitation exercise
Pregnant women
Minors
Adults under guardianship
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Guillaume MEURETTE
Phone
0240083027
Email
guillaume.meurette@chu-nantes.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Emilie DUCHALAIS
Phone
0240084322
Email
emilie.duchalais@gmail.com
Facility Information:
Facility Name
CHU Angers
City
Angers
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Antoine Hamy
Email
anhamy@chu-angers.fr
Facility Name
APHP-Hôpital Beaujon
City
Clichy
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yves Panis
Email
Yves.panis@bnj.aphp.fr
Facility Name
Clinic Jules Verne
City
Nantes
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Michel Balon
Email
jmbalon@mla.fr
Facility Name
CHU de Poitiers
City
Poitiers
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marie-Line Barussaud
Email
marie-line.barussaud@chupoitiers.fr
Facility Name
CHD Vendée
City
Roche Sur Yon
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eric Abet
Email
Emeric.abet@chdvendee.fr
Facility Name
CHU de Tours
City
Tours
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mehdi Ouaissi
Email
Mehdi.ouaissi@chu-tours.fr
12. IPD Sharing Statement
Learn more about this trial
"Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer"
We'll reach out to this number within 24 hrs